obesity drug news today october 21 2025 glp-1 gains meet modest dip 2024 was a record year
Description
Int J Obes (Lond)

Vergs B, Duvillard L, Pais de Barros JP, Bouillet B, Baillot-Rudoni S, Rouland A, et al
Science 373 , eabf8683 (2021)

These drugs have different formulations and dosing schedules
Glucagon receptor signaling in metabolic diseases
